Publicaciones en las que colabora con MARIA TERESA BERNAL DEL CASTILLO (16)

2024

  1. Correction to: Study of the intestinal microbiota composition and the effect of treatment with intensive chemotherapy in patients recovered from acute leukemia (Scientific Reports, (2024), 14, 1, (5585), 10.1038/s41598-024-56054-w)

    Scientific Reports

  2. Study of the intestinal microbiota composition and the effect of treatment with intensive chemotherapy in patients recovered from acute leukemia

    Scientific Reports, Vol. 14, Núm. 1

2023

  1. Evaluation of a Shotgun Metagenomics Approach for Detection of ESBL- and/or Carbapenemase-Producing Enterobacterales in Culture Negative Patients Recovered from Acute Leukemia

    Microorganisms, Vol. 11, Núm. 2

2020

  1. Expression of CD47 antigen in Reed–Sternberg cells as a new potential biomarker for classical Hodgkin lymphoma

    Clinical and Translational Oncology, Vol. 22, Núm. 5, pp. 782-785

2019

  1. Chromatin regulation by Histone H4 acetylation at Lysine 16 during cell death and differentiation in the myeloid compartment

    Nucleic Acids Research, Vol. 47, Núm. 10, pp. 5016-5037

  2. The value of adding surveillance cultures to fluoroquinolone prophylaxis in the management of multiresistant gram negative bacterial infections in acute myeloid leukemia

    Journal of Clinical Medicine, Vol. 8, Núm. 11

2018

  1. Correction to "Increasing TIMP3 expression by hypomethylating agents diminishes soluble MICA, MICB and ULBP2 shedding in acute myeloid leukemia, facilitating NK cell-mediated immune recognition" [Oncotarget. 2017; 8:31959-31976]. Doi: https://doi.org/10.18632/oncotarget.16657

    Oncotarget

2017

  1. Increasing TIMP3 expression by hypomethylating agents diminishes soluble MICA, MICB and ULBP2 shedding in acute myeloid leukemia, facilitating NK cell-mediated immune recognition

    Oncotarget, Vol. 8, Núm. 19, pp. 31959-31976

  2. The impact of antimicrobial prophylaxis in morbidity and infections during azacitidine treatment

    Annals of Hematology, Vol. 96, Núm. 11, pp. 1833-1840

2016

  1. Blood, sweat, and teARDS

    Critical Care Medicine

  2. Impact of initial ventilatory strategy in hematological patients with acute respiratory failure: A systematic review and meta-analysis

    Critical Care Medicine, Vol. 44, Núm. 7, pp. 1406-1413

  3. Loss of the proteostasis factor AIRAPL causes myeloid transformation by deregulating IGF-1 signaling

    Nature Medicine, Vol. 22, Núm. 1, pp. 91-96

2013

  1. Immune-dependent and independent antitumor activity of GM-CSF aberrantly expressed by mouse and human colorectal tumors

    Cancer Research, Vol. 73, Núm. 1, pp. 395-405

  2. Noninvasive ventilation in the critical hematological patient: Friend, enemy or both?

    Medicina Intensiva, Vol. 37, Núm. 7, pp. 441-442

  3. Survival of hematological patients after discharge from the intensive care unit: A prospective observational study

    Critical Care, Vol. 17, Núm. 6

2012

  1. Ventilatory support in critically ill hematology patients with respiratory failure

    Critical Care, Vol. 16, Núm. 4